Virta Health Stock
Online Specialty Medical Clinic
Sign up today and learn more about Virta Health Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Virta Health Stock
Virta is an online specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Our innovations in nutritional biochemistry, data science and digital tools combined with our clinical clinical expertise are shifting the diabetes treatment paradigm from management to reversal. Our mission - to reverse type 2 diabetes in 100 million people by 2025. 115 million US population with type 2 diabetes or prediabetes $300 billion Yearly spend in US alone on prediabetes and type 2 diabetes combined ~400 million Number of people with type 2 diabetes globally
Investors
Tiger Global Management
Flipkart, Delhivery, BharatPe, Databricks, Ather Energy, Grab, Chime, Ola, Relativity Space, Quikr
Venrock
Devoted Health, Zenefits, TAE Technologies, Dollar Shave Club, Lucid Motors, Dataminr, 6sense, AppNexus, Salsify, Astranis
Founders Fund
Lyft, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass, Zenefits
Creandum
Bolt, VOI Technology, Virta Health, Neo4j, Taxfix, Cake Bikes, Depop, Klarna
SciFi VC
Zymergen, PsiQuantum, Anchorage Digital, Synthego, Virta Health, Emulate
Funding History
March 2017 | $7.6M |
---|---|
March 2017 | $23.4M |
April 2018 | $42.5M |
August 2019 | $28.2M |
August 2019 | $65.0M |
November 2020 | $34.9M |
November 2020 | $30.0M |
March 2021 | $133M |
Management
Chief Executive Officer
Sami Inkinen
Chief Financial Officer
Alok Bhushan
Press
linkedin - Apr, 6 2024
Sami Inkinen on LinkedIn: Strong "class" of new Virta Health team members joining us this week to…biospace - Apr, 6 2024
Virta Health Announces First-of-its-Kind Peer-Reviewed Study Proving Its Approach Is an Effective Off-Ramp From GLP ...fiercehealthcare - Apr, 6 2024
Virta Health says it has the GLP-1 deprescription solution